Rho(D) Immune Globulin (Human) Shortage

• • RhoGAM Ultra-Filtered Plus intramuscular injection, Kedrion Biopharma, Inc., 1,500 units (300 mcg), syringe, 1 count, NDC 00562-7805-01
  • Rhophylac injection, CSL Behring, 1,500 units (300 mcg), 2 mL syringe, 10 count, NDC 44206-0300-10 - discontinued

• • CSL Behring has Rhophylac available to current customer and some extra for new customers depending on demand at any given time. They discontinued the 10-count presentation in August 2024.
  • Grifols has HyperRHO S/D Full Dose injection available.
  • Kedrion has RhoGAM on shortage due to the shortage of an active ingredient and manufacturing issues and plant maintenance requirements.
  • Kamada has WinRho available. All presentations of WinRho SDF have the same concentration. There is a letter describing how to dose WinRho SDF with different vial sizes at https://www.kamada.com/wp-content/uploads/2024/05/WINRHO-DHCP-letter-May-2024.pdf

• • HyperRHO S/D Full Dose intramuscular injection, Grifols, 1,500 units (300 mcg), syringe, 1 count, NDC 13533-0631-02
  • HyperRHO S/D Full Dose intramuscular injection, Grifols, 1,500 units (300 mcg), syringe, 10 count, NDC 13533-0631-11
  • RhoGAM Ultra-Filtered Plus intramuscular injection, Kedrion Biopharma, Inc., 1,500 units (300 mcg), syringe, 5 count, NDC 00562-7805-05
  • RhoGAM Ultra-Filtered Plus intramuscular injection, Kedrion Biopharma, Inc., 1,500 units (300 mcg), syringe, 25 count, NDC 00562-7805-25
  • Rhophylac injection, CSL Behring, 1,500 units (300 mcg), 2 mL syringe, 1 count, NDC 44206-0300-01
  • WinRho SDF injection, Kamada, 1,500 units (300 mcg)/1.3 mL, vial, 1 count, NDC 49591-0330-51
  • WinRho SDF injection, Kamada, 5,000 units (1,000 mcg)/4.4 mL, vial, 1 count, NDC 49591-0310-51
  • WinRho SDF, Kamada, 5,000 units (1,000 mcg)/4.4 mL, vial, 1 count, NDC 49591-0300-51

Estimated Resupply Dates

• • Kedrion has RhoGAM Ultra-Filtered Plus 1,500 units (300 mcg) syringes in 1 count on back order and the company cannot estimate a release date.